RITAZAREM - how to manage relapse in AAV

Was anyone really backing azathioprine against vitamin R in relapsed ANCA-associated vasculitis? Catch-up on the RCT here.

Welcome to #TenTweetNephJC

✳️10 tweet #NephJC catch-up ✳️

🌟Let’s recap the RITAZAREM trial - a rematch between Rituximab and Azathioprine as the maintenance agent of choice in relapsed ANCA-associated vasculitis.

🌟Have we witnessed the ultimate triumph of Rituximab? pic.twitter.com/HbFKhe6MKc

— Nephrology Journal Club (@NephJC) June 3, 2023